The area of tumor immunology impacts a variety of clinical and research specialties. The complexity of the malignant diseases’ etiology and pathogenesis requires continuing updates to the providers’ knowledge in order to understand the interventions and innovations which will impact care of patients.
The organizing committees for CITIM Conference 2017 bring together thought leaders from the USA and Europe to provide a comprehensive four-day curriculum related to the treatment, prevention, and diagnostic of malignant diseases diseases, as well as the cellular, molecular and genetic mechanisms of their development and therapy.
Who Should Attend: Physicians, researchers, students and healthcare providers who have an interest in the following areas: Tumor immunobiology, immune regulation (cytokines, growth factors, regulatory T cells, MDSC, dendritic cells, NK, macrophages, neutrophils, mast cells), inflammation and cancer, immunotherapy, vaccines, immunomodeling, immunomics, immune tolerance, immunomonitoring, stem cells, cancer stem cells, biomarkers and related disciplines.
CITIM 2017 Conference will be held in Hotel Ambassador, which is located in the center of a beautiful capital of Czech Republic.
Amber Kempf at 626-256-6405 x110 or amber.kempf [at] gtcbio.com
For more information on Media Relations, please contact:
Jennifer Chu at 626-256-6405 x105 or jennifer.chu [at] gtcbio.com